Clean Well Announces Share Buyback Program Amid Strong Financial Performance and Promising Pipeline Prospects | Dr Philippe Wolgen, CEO, Clinuvel Pharmaceuticals Ltd. 00:10:00

Share On Facebook Share On Twitter

In a shareholder meeting, Clean Well reveals a share buyback program, highlighting consecutive growth, sound financials, and promising research progress, affirming confidence in its future prospects.

Recent Videos